Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal.

We have reported previously on the first spontaneously immortalized, nonmalignant human breast epithelial cell line, HMT-3522, which is entirely dependent on exogenous epidermal growth factor (EGF). In passage 118, cells were adapted to grow in medium without EGF and a new growth-transformed subline, HMT-3522/gt-1, was generated and propagated at high growth rate without exogenous EGF (Madsen et al., Cancer Res., 52: 1210-1217, 1992). Here we have used this subline and the continuum of the parent line, HMT-3522/wt, to pose the question whether a relevant change in a physiological parameter of the microenvironment will induce malignant transformation. The two cell lines were cultured under identical conditions with the only exception that EGF was omitted in the medium for gt-1. Initially, wt and gt-1 were identical in terms of karyotype as well as morphology, growth rate, and protein expression as revealed by two-dimensional gel electrophoresis. A highly dramatic shift to phenotype was observed in passage 238 when the gt-1 line became tumorigenic in nude mice. After two mouse-culture passages, the resulting malignantly transformed cell line (HMT-3522/mt-1) was refractory to the growth-modulating effect of EGF and presented an extra copy of a chromosome marker, 7q-, as the only cytogenetic difference from the gt-1. Our results suggest that microenvironmental cues are powerful factors in the induction of malignancy. A major role of EGF receptor in the malignant transformation is emphasized by loss of EGF sensitivity and acquisition of an extra chromosome 7p harboring the EGF receptor gene. We hypothesize that during premalignant hyperplasia, a population of EGF/transforming growth factor alpha autonomous epithelial cells in situ may develop as a consequence of local transforming growth factor alpha deprivation, a condition reflected in the culture model as autonomy after EGF withdrawal.

[1]  R. Newbold,et al.  Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens , 1982, Nature.

[2]  D. Sheer,et al.  The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients , 1984, International journal of cancer.

[3]  M N Pollak,et al.  MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. , 1985, Biochemical and biophysical research communications.

[4]  D. Goeddel,et al.  Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation , 1986, Cell.

[5]  T. A. Avitts,et al.  Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. E. Chang In vitro transformation of human epithelial cells. , 1986, Biochimica et biophysica acta.

[7]  D. Fabbro,et al.  Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[8]  How valid is the concept of hormonal carcinogenesis in human neoplasias? , 1987, Anticancer research.

[9]  D. Gruenert Differentiated properties of human epithelial cells transformed in vitro , 1987 .

[10]  C. Harris Human tissues and cells in carcinogenesis research. , 1987, Cancer research.

[11]  B. Henderson,et al.  Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. , 1988, Cancer research.

[12]  J L Kelsey,et al.  Breast cancer epidemiology. , 1988, Cancer research.

[13]  R. Dickson,et al.  Mechanisms of normal and malignant breast epithelial growth regulation. , 1989, Journal of steroid biochemistry.

[14]  I. Forsyth Growth factors in mammary gland function. , 1989, Journal of reproduction and fertility.

[15]  P. Briand,et al.  Cytogenetic analysis of in vitro karyotype evolution in a cell line established from nonmalignant human mammary epithelium. , 1988, Cancer genetics and cytogenetics.

[16]  R. Clarke,et al.  The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo. , 1989, Molecular endocrinology.

[17]  J. Smith,et al.  Identification of alpha transforming growth factor as a possible local trophic agent for the mammary gland , 1989, Journal of cellular physiology.

[18]  Jose Russo,et al.  Human Breast Epithelial Cell Line, MCF-10 Isolation and Characterization of a Spontaneously Immortalized , 2006 .

[19]  Joël Vandekerckhove,et al.  Comprehensive two‐dimensional gel protein databases offer a global approach to the analysis of human cells: The transformed amnion cells (AMA) master database and its link to genome DNA sequence data , 1990, Electrophoresis.

[20]  B. Hogan,et al.  Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice , 1990, Cell.

[21]  R. Palmiter,et al.  Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast , 1990, Cell.

[22]  Masui,et al.  Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[23]  G. Merlino,et al.  TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas , 1990, Cell.

[24]  M. Fernö,et al.  Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. , 1992, Acta oncologica.

[25]  N. Carter,et al.  Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. , 1992, Genomics.

[26]  P. Briand,et al.  Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements. , 1992, Cancer research.

[27]  J. Trent,et al.  Clonal chromosome abnormalities in human breast carcinomas II. Thirty‐four cases with metastatic disease , 1993, Genes, chromosomes & cancer.

[28]  J. Trent,et al.  Clonal chromosome abnormalities in human breast carcinomas I. Twenty‐eight cases with primary disease , 1993, Genes, chromosomes & cancer.

[29]  B. Johansson,et al.  Trisomy 7 in nonneoplastic cells , 1993, Genes, chromosomes & cancer.

[30]  F. Miller,et al.  The MCF10 family of spontaneously immortalized human breast epithelial cell lines: models of neoplastic progression. , 1993, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[31]  P. Briand,et al.  Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522. , 1994, Experimental cell research.

[32]  P. Briand,et al.  In vitro karyotype evolution and cytogenetic instability in the non-tumorigenic human breast epithelial cell line HMT-3522. , 1994, Cancer genetics and cytogenetics.

[33]  K. Kinzler,et al.  Has the breast cancer gene been found? , 1994, Cell.

[34]  Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. , 1995, Molecular and cellular biology.

[35]  M. Bissell,et al.  The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.

[36]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[37]  R. Smith,et al.  Breast cancer epidemiology. , 2018 .

[38]  Growth factors as mediators of malignant tumor progression , 1993, Cancer and Metastasis Reviews.

[39]  P. Rudland,et al.  Immunolocalization of alpha-transforming growth factor in the developing rat mammary gland in vivo, rat mammary cells in vitro and in human breast diseases , 1994, The Histochemical Journal.

[40]  V. Schirrmacher,et al.  EGF receptor in neoplasia and metastasis , 1993, Cancer and Metastasis Reviews.

[41]  J. Bartek,et al.  Keratin 19 expression in the adult and developing human mammary gland , 1990, The Histochemical Journal.